ESR1 and COVID-19: After assessing non-cytokine markers of inflammation in COVID-19 patients (POP2), we found that for every 1-point increase in ESR, CRP, and WBC, there was statistical worsening in ventilation, ICU admission, and mortality (ESR not significant).